These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26441114)

  • 21. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorbable Suspension Sutures: Recommendations for Use in a Multimodal Nonsurgical Approach to Facial Rejuvenation.
    Fabi SG; Weiss R; Weinkle SH
    J Drugs Dermatol; 2021 Jan; 20(1):23-29. PubMed ID: 33400414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of nontraditional fillers and neuromodulators to improve patient satisfaction.
    Wirtzer A
    Dermatol Surg; 2015 Apr; 41 Suppl 1():S163-4. PubMed ID: 25828042
    [No Abstract]   [Full Text] [Related]  

  • 24. Pachydermoperiostosis: aesthetic treatment of prematurely aging face with facelift and botulinum toxin a.
    Bingol UA; Cinar C
    J Craniofac Surg; 2014 Nov; 25(6):e563-4. PubMed ID: 25377981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aesthetics and Rejuvenation of the Temple.
    Rihani J
    Facial Plast Surg; 2018 Apr; 34(2):159-163. PubMed ID: 29631286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AbobotulinumtoxinA (Dysport
    Field M; Splevins A; Picaut P; van der Schans M; Langenberg J; Noort D; Snyder D; Foster K
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of botulinum toxins: past, present, and future.
    Cartee TV; Monheit GD
    Clin Plast Surg; 2011 Jul; 38(3):409-26, vi. PubMed ID: 21824539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacology of Aesthetic Medicines.
    Dunlop N; Abramowicz S; Fisher E
    Oral Maxillofac Surg Clin North Am; 2022 Feb; 34(1):189-200. PubMed ID: 34711465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injectable agents for facial rejuvenation: botulinum toxin and dermal filling agents.
    Mandeville JT; Rubin PA
    Int Ophthalmol Clin; 2004; 44(1):189-212. PubMed ID: 14704531
    [No Abstract]   [Full Text] [Related]  

  • 30. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina.
    Banegas RA; Farache F; Rancati A; Chain M; Gallagher CJ; Chapman MA; Caulkins CA
    Aesthet Surg J; 2013 Sep; 33(7):1039-45. PubMed ID: 23990584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The shift toward minimally invasive aesthetic facial rejuvenation.
    Goldberg RA
    Arch Ophthalmol; 2010 Sep; 128(9):1200-1. PubMed ID: 20837806
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.
    Jandhyala R
    J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):720-31. PubMed ID: 22225675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxins.
    Ong AA; Sherris DA
    Facial Plast Surg; 2019 Jun; 35(3):230-238. PubMed ID: 31189195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum neurotoxin type B--a rapid wrinkle reducer.
    Jacob CI
    Semin Cutan Med Surg; 2003 Jun; 22(2):131-5. PubMed ID: 12877232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correcting age-related changes in the face by use of injectable fillers and neurotoxins.
    Rubin MG; Cox SE; Kaminer MS; Solish N
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S81-4. PubMed ID: 25268602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Update on botulinum toxin for facial aesthetics.
    Cather JC; Cather JC; Menter A
    Dermatol Clin; 2002 Oct; 20(4):749-61. PubMed ID: 12380062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of AbobotulinumtoxinA (Dysport).
    Lorenc ZP; Kenkel JM; Fagien S; Hirmand H; Nestor MS; Sclafani AP; Sykes JM; Waldorf HA
    Aesthet Surg J; 2013 Mar; 33(1 Suppl):13S-7S. PubMed ID: 23515194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on neurotoxins for facial rejuvenation: what they are, how they work, and how to effectively and safely use them.
    Brennan C
    Plast Surg Nurs; 2015; 35(2):69-75. PubMed ID: 26020471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum neurotoxin type A-ABO (Dysport): clinical indications and practice guide.
    Matarasso A; Shafer D
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S72-9. PubMed ID: 19945008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.